nitrendipine has been researched along with Arterial Diseases, Carotid in 1 studies
Nitrendipine: A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
nitrendipine : A dihydropyridine that is 1,4-dihydropyridine substituted by methyl groups at positions 2 and 6, a 3-nitrophenyl group at position 4, a ethoxycarbonyl group at position 3 and a methoxycarbonyl group at position 5. It is a calcium-channel blocker used in the treatment of hypertension.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nitrendipine was administered daily in doses of 20 mg during 1 month." | 6.67 | [Regional arterial hemodynamics and carotid circulation in essential arterial hypertension. Effect of nitrendipine in patients over 40 years of age]. ( Asmar, R; Benetos, A; Ghodsi, N; Meilhac, B; Safar, M, 1993) |
| "Nitrendipine was administered daily in doses of 20 mg during 1 month." | 2.67 | [Regional arterial hemodynamics and carotid circulation in essential arterial hypertension. Effect of nitrendipine in patients over 40 years of age]. ( Asmar, R; Benetos, A; Ghodsi, N; Meilhac, B; Safar, M, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asmar, R | 1 |
| Benetos, A | 1 |
| Ghodsi, N | 1 |
| Meilhac, B | 1 |
| Safar, M | 1 |
1 trial available for nitrendipine and Arterial Diseases, Carotid
| Article | Year |
|---|---|
[Regional arterial hemodynamics and carotid circulation in essential arterial hypertension. Effect of nitrendipine in patients over 40 years of age].
Topics: Adult; Age Factors; Blood Flow Velocity; Blood Pressure Determination; Carotid Artery Diseases; Doub | 1993 |